136 related articles for article (PubMed ID: 28647403)
1. Prognostic Factors and Outcomes of Adult Lymphoblastic Lymphoma in the United States.
El-Fattah MA
Clin Lymphoma Myeloma Leuk; 2017 Aug; 17(8):498-505.e6. PubMed ID: 28647403
[TBL] [Abstract][Full Text] [Related]
2. Natural Killer/T-cell Neoplasms: Analysis of Incidence, Patient Characteristics, and Survival Outcomes in the United States.
Kommalapati A; Tella SH; Ganti AK; Armitage JO
Clin Lymphoma Myeloma Leuk; 2018 Jul; 18(7):475-479. PubMed ID: 29752210
[TBL] [Abstract][Full Text] [Related]
3. Secondary acute lymphoblastic leukemia is an independent predictor of poor prognosis.
Giri S; Chi M; Johnson B; McCormick D; Jamy O; Bhatt VR; Martin MG
Leuk Res; 2015 Dec; 39(12):1342-6. PubMed ID: 26427729
[TBL] [Abstract][Full Text] [Related]
4. [Lymphoblastic lymphoma and acute lymphoblastic leukemia: a clinicopathologic, immunophenotypic and prognostic study in 153 Chinese patients].
Pan Y; Li GD; Liu WP; Zhang WY; Tang Y; Li FY
Zhonghua Bing Li Xue Za Zhi; 2009 Dec; 38(12):810-5. PubMed ID: 20193455
[TBL] [Abstract][Full Text] [Related]
5. Survival of Subcutaneous Panniculitis-Like T-Cell Lymphoma and Peripheral T-Cell Lymphoma Not Otherwise Specified: A Propensity-Matched Analysis of the Surveillance, Epidemiology, and End Results Database.
Bhatt VR; Giri S; Verma V; Manandhar S; Pathak R; Bociek RG; Vose JM; Armitage JO
Clin Lymphoma Myeloma Leuk; 2016 Jul; 16(7):373-8. PubMed ID: 27349764
[TBL] [Abstract][Full Text] [Related]
6. [Prognosis and treatment strategies of primary B-cell and NK/T-cell nasopharyngeal non-Hodgkin's lymphoma at early stage].
Zou GR; Zhang YJ; Xie FY; Zheng W; Li HX; Xia YF; Lin TY; Lu TX
Ai Zheng; 2006 Dec; 25(12):1543-9. PubMed ID: 17166383
[TBL] [Abstract][Full Text] [Related]
7. Pediatric-Like Acute Lymphoblastic Leukemia Therapy in Adults With Lymphoblastic Lymphoma: The GRAALL-LYSA LL03 Study.
Lepretre S; Touzart A; Vermeulin T; Picquenot JM; Tanguy-Schmidt A; Salles G; Lamy T; Béné MC; Raffoux E; Huguet F; Chevallier P; Bologna S; Bouabdallah R; Benichou J; Brière J; Moreau A; Tallon-Simon V; Seris S; Graux C; Asnafi V; Ifrah N; Macintyre E; Dombret H
J Clin Oncol; 2016 Feb; 34(6):572-80. PubMed ID: 26644537
[TBL] [Abstract][Full Text] [Related]
8. Epidemiology and prognostic indicators in laryngeal lymphoma: A population-based analysis.
Hong SA; Tajudeen BA; Choi S; Husain IA
Laryngoscope; 2018 Sep; 128(9):2044-2049. PubMed ID: 29392765
[TBL] [Abstract][Full Text] [Related]
9. Survival of patients with malignant primary osseous spinal neoplasms: results from the Surveillance, Epidemiology, and End Results (SEER) database from 1973 to 2003.
Mukherjee D; Chaichana KL; Gokaslan ZL; Aaronson O; Cheng JS; McGirt MJ
J Neurosurg Spine; 2011 Feb; 14(2):143-50. PubMed ID: 21184634
[TBL] [Abstract][Full Text] [Related]
10. Sites of extranodal involvement are prognostic in patients with diffuse large B-cell lymphoma in the rituximab era: an analysis of the Surveillance, Epidemiology and End Results database.
Castillo JJ; Winer ES; Olszewski AJ
Am J Hematol; 2014 Mar; 89(3):310-4. PubMed ID: 24273125
[TBL] [Abstract][Full Text] [Related]
11. Extranodal natural killer/T-Cell lymphoma: A population-based comparison of sinonasal and extranasal disease.
Vazquez A; Khan MN; Blake DM; Sanghvi S; Baredes S; Eloy JA
Laryngoscope; 2014 Apr; 124(4):888-95. PubMed ID: 24114591
[TBL] [Abstract][Full Text] [Related]
12. Cutaneous extranodal natural killer/T-cell lymphoma: a comparative clinicohistopathologic and survival outcome analysis of 45 cases according to the primary tumor site.
Lee WJ; Jung JM; Won CH; Chang SE; Choi JH; Chan Moon K; Park CS; Huh J; Lee MW
J Am Acad Dermatol; 2014 Jun; 70(6):1002-9. PubMed ID: 24629518
[TBL] [Abstract][Full Text] [Related]
13. Epidemiology of Nasopharyngeal Lymphoma in the United States: A Population-Based Analysis of 1119 Cases.
Han AY; Kuan EC; Alonso JE; Badran KW; St John MA
Otolaryngol Head Neck Surg; 2017 May; 156(5):870-876. PubMed ID: 28322119
[TBL] [Abstract][Full Text] [Related]
14. Trends in survival outcomes of B-lineage acute lymphoblastic leukemia in elderly patients: analysis of Surveillance, Epidemiology, and End Results database.
Guru Murthy GS; Venkitachalam R; Mehta P
Leuk Lymphoma; 2015; 56(8):2296-300. PubMed ID: 25495170
[TBL] [Abstract][Full Text] [Related]
15. Outcomes of patients with inflammatory breast cancer by hormone receptor- and HER2-defined molecular subtypes: A population-based study from the SEER program.
Li J; Xia Y; Wu Q; Zhu S; Chen C; Yang W; Wei W; Sun S
Oncotarget; 2017 Jul; 8(30):49370-49379. PubMed ID: 28472761
[TBL] [Abstract][Full Text] [Related]
16. Parotid gland lymphoma: prognostic analysis of 2140 patients.
Feinstein AJ; Ciarleglio MM; Cong X; Otremba MD; Judson BL
Laryngoscope; 2013 May; 123(5):1199-203. PubMed ID: 23576299
[TBL] [Abstract][Full Text] [Related]
17. Epidemiology, Tumor Characteristics, and Survival in Patients With Primary Pancreatic Lymphoma: A Large Population-based Study Using the SEER Database.
Mukhija D; Nagpal SJS; Sohal DPS
Am J Clin Oncol; 2019 May; 42(5):454-458. PubMed ID: 30950860
[TBL] [Abstract][Full Text] [Related]
18. Understanding disparities in leukemia: a national study.
Patel MI; Ma Y; Mitchell BS; Rhoads KF
Cancer Causes Control; 2012 Nov; 23(11):1831-7. PubMed ID: 22971999
[TBL] [Abstract][Full Text] [Related]
19. Racial differences in three major NHL subtypes: descriptive epidemiology.
Li Y; Wang Y; Wang Z; Yi D; Ma S
Cancer Epidemiol; 2015 Feb; 39(1):8-13. PubMed ID: 25560974
[TBL] [Abstract][Full Text] [Related]
20. Improved survival with postoperative radiotherapy in thymic carcinoma: A propensity-matched analysis of Surveillance, Epidemiology, and End Results (SEER) database.
Lim YJ; Song C; Kim JS
Lung Cancer; 2017 Jun; 108():161-167. PubMed ID: 28625630
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
